List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 451 studies with search of: cord blood
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
Conditions: Hematological Malignancy;   Bone Marrow Failure Syndrome
Interventions: Drug: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders;   Radiation: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders;   Procedure: Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders
2 Recruiting Randomized Double Cord Blood Transplant Study
Conditions: Leukemia, Lymphocytic, Acute;   Leukemia, Myelocytic, Acute;   Leukemia, Myeloid, Chronic;   Lymphoma, Non-Hodgkin
Interventions: Procedure: Expanded allogeneic cord blood (CB);   Procedure: One Unmanipulated and One Expanded Cord Blood Unit
3 Recruiting Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Other Hematological Disorders;   Metabolic Storage Diseases
Intervention: Other: Search individual cord blood banks
4 Suspended Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
Conditions: Acute Myeloid Leukemia;   Leukemia, Lymphoblastic, Acute;   Leukemia, Bilineage, Acute;   Leukemia, Myeloid, Chronic
Intervention: Device: Ex vivo expansion of cord blood
5 Recruiting Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
Conditions: MDS;   Anemia, Aplastic;   Inborn Errors of Metabolism;   Congenital Marrow Failure;   Congenital Immunodeficiency Syndrome
Intervention: Biological: ALDHbr Umbilical Cord Blood Cells
6 Recruiting Infusion of Expanded Cord Blood T Cells
Conditions: Stem Cell Transplantation;   Leukemia;   Lymphoma;   Pediatrics
Interventions: Radiation: Total Body Irradiation (TBI);   Drug: Melphalan;   Drug: Thiotepa;   Drug: Fludarabine;   Drug: Rituximab;   Drug: Etoposide;   Drug: Anti-thymocyte globulin (ATG);   Drug: Mycophenolate Mofetil (MMF);   Drug: Tacrolimus;   Procedure: Cord Blood Infusion;   Drug: G-CSF;   Procedure: Ex vivo expanded T cell Infusion
7 Recruiting Reduced Intensity, Sequential Double Umbilical Cord Blood Transplantation Using Prostaglandin E2 (PGE2)
Conditions: Hematologic Malignancies;   Allogeneic Stem Cell Transplantation
Interventions: Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Drug: Sirolimus;   Drug: Tacrolimus;   Other: Ex-vivo 16, 16 dimethyl-prostaglandin E2 expansion
8 Suspended T-Regulatory Cell Infusion After an Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorder
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Precancerous/Nonmalignant Condition
Interventions: Biological: umbilical cord blood-derived lymphocyte therapy;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
9 Recruiting Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Other: Cord blood transplantation
10 Recruiting Adult Double Cord Blood Transplant Study
Conditions: Cord Blood Stem Cell Transplantation;   Hematologic Malignancies
Intervention: Procedure: Cord blood transplantation
11 Recruiting Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Condition: Neonatal Hypoxic Ischemic Encephalopathy
Interventions: Other: autologous cord blood;   Other: no intervention
12 Recruiting A Phase II Study of Umbilical Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma;   Aplastic Anemia
Interventions: Biological: Umbilical Cord Blood Transplantation After Myeloablative Conditioning;   Biological: Umbilical Cord Blood Transplantation After Reduced-Intensity Conditioning
13 Active, not recruiting Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Secondary Myelofibrosis
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
14 Recruiting Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   NK Cell Lymphoblastic Leukemia
Interventions: Biological: Single Cord Blood Unit Transplantation;   Biological: Double Cord Blood Unit Transplantation
15 Recruiting Intraosseous Infusion of Unrelated Cord Blood Grafts
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome
Intervention: Procedure: cord blood infusion
16 Recruiting Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Conditions: Leukemia;   Non-Hodgkins Lymphoma;   Hodgkins Lymphoma;   MDS;   Multiple Myeloma
Interventions: Drug: EPOCH-F/R;   Drug: FLAG;   Drug: Transplant Preparative Regimen (Flu/Cy/Mes);   Drug: GVHD Prophylaxis (tacrolimus and sirolimus);   Procedure: Double Cord Blood Transplantation
17 Recruiting Cellular Therapy With Cord Blood Cells
Conditions: Multiple Myeloma;   Leukemia;   Lymphoma
Interventions: Drug: Fludarabine;   Drug: Melphalan;   Procedure: Umbilical Cord Blood;   Drug: Rituximab;   Other: Peripheral Blood Stem Cell Infusion
18 Active, not recruiting Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin, and Umbilical Cord Blood Transplant in Treating Patients With Refractory Hematologic Cancers or Other Diseases
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: natural killer cell therapy;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: mycophenolate mofetil;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
19 Recruiting Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Non-Hodgkin Lymphoma;   Myelodysplastic Syndromes
Intervention: Procedure: Cord Blood Transplant
20 Recruiting New York Blood Center National Cord Blood Program
Conditions: Leukemia;   Lymphoma;   Genetic Disease;   Severe Aplastic Anemia;   Myelodysplasia
Interventions: Procedure: Umbilical Cord Blood Hematopoietic Stem Cell Transplantation;   Procedure: Umbilical Cord Blood Transplantation

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services